tiprankstipranks
Trending News
More News >

Swedencare AB: Strategic Initiatives and Growth Prospects Underpin Buy Rating Despite Mixed 1Q25 Results

In a report released today, Adela Dashian from Jefferies maintained a Buy rating on Swedencare AB (7XYResearch Report), with a price target of SEK60.00.

Protect Your Portfolio Against Market Uncertainty

Adela Dashian’s rating is based on a combination of factors that highlight Swedencare AB’s potential for future growth despite its mixed 1Q25 results. The company reported a 7% year-over-year increase in net revenue, with a 5% organic growth, indicating a positive trend in its core business operations. Although the operational EBITDA saw a decline of 10% year-over-year, the expected launch of NaturVet products in Walmart is anticipated to boost sales in the upcoming quarter.
Moreover, Swedencare’s strategic investments in trade fairs and rebranding efforts, particularly with NaturVet, are expected to enhance its market presence and drive organic growth to double-digit figures by the end of 2025. The company’s local manufacturing and sourcing capabilities are also seen as advantageous, minimizing the impact of tariffs. Despite the current challenges, these strategic initiatives and growth prospects underpin Adela Dashian’s Buy rating for Swedencare AB.

Disclaimer & DisclosureReport an Issue